Thymoquinone: fifty years of success in the battle against cancer models

•This year marks 50 years since thymoquinone was isolated from black seed.•Thymoquinone has had a long history of battling cancer in vitro and in vivo.•Thymoquinone modulates nine of the ten hallmarks of cancer.•There are no controlled Phase I clinical studies on thymoquinone in human tumors. Thymoq...

Full description

Saved in:
Bibliographic Details
Published in:Drug discovery today 2014-01, Vol.19 (1), p.18-30
Main Authors: Schneider-Stock, Regine, Fakhoury, Isabelle H., Zaki, Angela M., El-Baba, Chirine O., Gali-Muhtasib, Hala U.
Format: Article
Language:English
Subjects:
Animals
Antineoplastic Agents, Phytogenic - chemistry
Antineoplastic Agents, Phytogenic - isolation & purification
Antineoplastic Agents, Phytogenic - therapeutic use
Benzoquinones - chemistry
Benzoquinones - isolation & purification
Benzoquinones - therapeutic use
Disease Models, Animal
Humans
Neoplasms - drug therapy
Neoplasms - pathology
Nigella sativa
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•This year marks 50 years since thymoquinone was isolated from black seed.•Thymoquinone has had a long history of battling cancer in vitro and in vivo.•Thymoquinone modulates nine of the ten hallmarks of cancer.•There are no controlled Phase I clinical studies on thymoquinone in human tumors. Thymoquinone (TQ), the main active constituent of black seed essential oil, exhibits promising effects against inflammatory diseases and cancer. TQ, modulates signaling pathways that are key to cancer progression, and enhances the anticancer potential of clinical drugs while reducing their toxic side effects. Considering that TQ was isolated 50 years ago, this review focuses on TQ's chemical and pharmacological properties and the latest advances in TQ analog design and nanoformulation. We discuss our current state of knowledge of TQ's adjuvant potential and in vivo antitumor activity and highlight its ability to modulate the hallmarks of cancer. Reviewing the anticancer effects and underlying molecular targets of thymoquinone, a molecule with promising biological activities that was isolated 50 years ago, is of crucial importance for its clinical translation.
ISSN:1359-6446
1878-5832
DOI:10.1016/j.drudis.2013.08.021